The company's vaccine candidate -Covaxin- has been developed in
collaboration with the Indian Council of Medical Research (ICMR) -
National Institute of Virology (NIV) using inactivated Sars-Cov-2, the
virus that causes COVID-19.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bharat-biotech-to-launch-covaxin-in-q2-2021/articleshow/78979220.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment